MEDINET Co., Ltd.
TSE:2370.T
42 (JPY) • At close November 1, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | MEDINET Co., Ltd. |
Symbool | 2370.T |
Munteenheid | JPY |
Prijs | 42 |
Beurswaarde | 11,109,627,270 |
Dividendpercentage | 0% |
52-weken bereik | 37 - 60 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Kanenao Kubushiro |
Website | https://www.medinet-inc.co.jp |
An error occurred while fetching data.
Over MEDINET Co., Ltd.
MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. Its solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy. The company also manufactures regenerative medical/investigational and specified cell products. In addition,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (JPY)
Cijfers zijn in miljoenen (JPY)